Cancer antigens: immune recognition of self and altered self.
作者信息
Houghton A N
机构信息
Memorial Sloan-Kettering Cancer Center, New York.
出版信息
J Exp Med. 1994 Jul 1;180(1):1-4. doi: 10.1084/jem.180.1.1.
Abstract
摘要
相似文献
1
Cancer antigens: immune recognition of self and altered self.癌症抗原：自身及改变的自身的免疫识别
J Exp Med. 1994 Jul 1;180(1):1-4. doi: 10.1084/jem.180.1.1.
2
Immune recognition of self in immunity against cancer.癌症免疫中对自身的免疫识别。
J Clin Invest. 2004 Aug;114(4):468-71. doi: 10.1172/JCI22685.
3
A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.一种多价细胞疫苗可诱导针对慢性淋巴细胞性B细胞白血病中过度表达的特定自身抗原的T细胞反应。
J Immunother. 2008 Oct;31(8):723-30. doi: 10.1097/CJI.0b013e318183af26.
4
Overexpressed oncogenic tumor-self antigens.过度表达的致癌肿瘤自身抗原。
Hum Vaccin Immunother. 2014;10(11):3297-305. doi: 10.4161/hv.29475.
5
[Tumor antigen-specific cytotoxic T lymphocytes and cancer immunotherapy - review].[肿瘤抗原特异性细胞毒性T淋巴细胞与癌症免疫治疗——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):244-8.
6
[Cytotoxic T-cell immune response against melanoma antigens].针对黑色素瘤抗原的细胞毒性T细胞免疫反应
Ann Dermatol Venereol. 1998 Nov;125 Suppl 2:S34-6.
7
Cytotoxic T lymphocyte responses to spontaneous tumors: immunogenicity dependent on the recognition of processed tumor antigens.
J Immunol. 1983 May;130(5):2005-7.
8
9
10
[Tumor specific antigen and cytotoxic T lymphocytes].[肿瘤特异性抗原与细胞毒性T淋巴细胞]
Nihon Rinsho. 2005 Apr;63 Suppl 4:568-73.
引用本文的文献
1
Advancing cancer drug development with mechanistic mathematical modeling: bridging the gap between theory and practice.运用机制数学建模推进癌症药物研发：弥合理论与实践之间的差距。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):581-604. doi: 10.1007/s10928-024-09930-x. Epub 2024 Jun 21.
2
Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect.单剂量注射纳米疫苗水凝胶，实现大肿瘤的强大免疫治疗和远隔效应。
Sci Adv. 2023 Jul 14;9(28):eade6257. doi: 10.1126/sciadv.ade6257.
3
Reuniting philosophy and science to advance cancer research.将哲学与科学重新结合起来，以推进癌症研究。
Biol Rev Camb Philos Soc. 2023 Oct;98(5):1668-1686. doi: 10.1111/brv.12971. Epub 2023 May 8.
4
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.一种针对大鼠 BORIS（CTCFL）的治疗性疫苗，用于治疗大鼠乳腺癌肿瘤。
Int J Mol Sci. 2023 Mar 22;24(6):5976. doi: 10.3390/ijms24065976.
5
Nanomaterials-Based Novel Immune Strategies in Clinical Translation for Cancer Therapy.基于纳米材料的新型免疫策略在癌症治疗的临床转化。
Molecules. 2023 Jan 26;28(3):1216. doi: 10.3390/molecules28031216.
6
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.液体活检在肺癌中的应用：筛查项目的最新进展和展望。
Int J Mol Sci. 2023 Jan 28;24(3):2505. doi: 10.3390/ijms24032505.
7
Locally sourced: site-specific immune barriers to metastasis.局部来源：转移的特定部位免疫屏障。
Nat Rev Immunol. 2023 Aug;23(8):522-538. doi: 10.1038/s41577-023-00836-2. Epub 2023 Feb 7.
8
An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity.一种体内筛选增强抗肿瘤免疫原性的短肽模拟物的方法。
Cancer Immunol Res. 2022 Mar 1;10(3):314-326. doi: 10.1158/2326-6066.CIR-21-0332.
9
Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases.利用异种细胞作为治疗疾病的治疗剂。
Cell Transplant. 2021 Jan-Dec;30:9636897211011995. doi: 10.1177/09636897211011995.
10
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics.用于癌症治疗的纳米材料介导的免疫调节
Front Chem. 2021 Feb 23;9:629635. doi: 10.3389/fchem.2021.629635. eCollection 2021.
本文引用的文献
1
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.甲基胆蒽诱发的原种系小鼠肿瘤的抗原特性。
Cancer Res. 1953 Dec;13(12):835-7.
2
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.酪氨酸酶基因编码一种抗原，该抗原可被HLA - A2黑色素瘤上的自体细胞溶解性T淋巴细胞识别。
J Exp Med. 1993 Aug 1;178(2):489-95. doi: 10.1084/jem.178.2.489.
3
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.编码一种被浸润肿瘤的自体T细胞识别的共享人类黑色素瘤抗原的基因的克隆。
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3515-9. doi: 10.1073/pnas.91.9.3515.
4
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.人类基因MAGE - 3编码一种抗原，该抗原可被自体溶细胞性T淋巴细胞识别，存在于黑色素瘤中。
J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921.
5
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.黑色素细胞谱系特异性抗原gp100可被黑色素瘤来源的肿瘤浸润淋巴细胞识别。
J Exp Med. 1994 Mar 1;179(3):1005-9. doi: 10.1084/jem.179.3.1005.
6
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.一种被五条黑色素瘤特异性人细胞毒性T细胞系识别的肽的鉴定。
Science. 1994 Apr 29;264(5159):716-9. doi: 10.1126/science.7513441.
7
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.乳腺癌患者中存在的针对HER-2/neu蛋白的T细胞和抗体免疫。
Cancer Res. 1994 Jan 1;54(1):16-20.
8
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.黑色素细胞和黑色素瘤的表面抗原。黑色素细胞分化标志物和黑色素瘤亚群。
J Exp Med. 1982 Dec 1;156(6):1755-66. doi: 10.1084/jem.156.6.1755.
9
Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.通过诱变获得的免疫原性变体对两种自发性小鼠白血病的保护作用。
J Exp Med. 1983 Jun 1;157(6):1992-2001. doi: 10.1084/jem.157.6.1992.
10
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.人类黑色素瘤的1类（独特）肿瘤抗原。通过自身抗体鉴定一种90,000道尔顿的细胞表面糖蛋白。
J Exp Med. 1984 Oct 1;160(4):1219-33. doi: 10.1084/jem.160.4.1219.
Zotero 插件